Most studies on circulating inflammatory biomarkers and brain aging outcomes investigated clinical diagnosis of dementia, rather than more subtle cognitive decline, and focused on one or a few major inflammatory biomarkers, mostly pro-inflammatory, such as C-Reactive Protein (CRP), IL-6, or Tumor Necrosis Factor α (TNF-α)17. This evidence concerns the gene CRP and dementia.